Navignostics
Pre-clinicalNavignostics combines highly multiplex tumor imaging with advanced data analytics for personalized cancer treatments.
Founded
2022
Focus
Diagnostics
About
Navignostics combines highly multiplex tumor imaging with advanced data analytics for personalized cancer treatments.
Funding History
2Total raised: $8.5M
Series A$6MAdjuvant CapitalJun 15, 2023
Seed$2.5MZürcher KantonalbankOct 15, 2021
Company Info
TypePrivate
Founded2022
LocationZurich, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile